Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy. 2013

Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Institute for Stem Cell Biology and Regenerative Medicine, Clinical Sciences Research Center, Stanford University School of Medicine, Stanford, California 94305, USA.

Duchenne muscular dystrophy (DMD), the most common inherited muscular dystrophy of childhood, leads to death due to cardiorespiratory failure. Paradoxically, mdx mice with the same genetic deficiency of dystrophin exhibit minimal cardiac dysfunction, impeding the development of therapies. We postulated that the difference between mdx and DMD might result from differences in telomere lengths in mice and humans. We show here that, like DMD patients, mice that lack dystrophin and have shortened telomeres (mdx/mTR(KO)) develop severe functional cardiac deficits including ventricular dilation, contractile and conductance dysfunction, and accelerated mortality. These cardiac defects are accompanied by telomere erosion, mitochondrial fragmentation and increased oxidative stress. Treatment with antioxidants significantly retards the onset of cardiac dysfunction and death of mdx/mTR(KO) mice. In corroboration, all four of the DMD patients analysed had 45% shorter telomeres in their cardiomyocytes relative to age- and sex-matched controls. We propose that the demands of contraction in the absence of dystrophin coupled with increased oxidative stress conspire to accelerate telomere erosion culminating in cardiac failure and death. These findings provide strong support for a link between telomere length and dystrophin deficiency in the etiology of dilated cardiomyopathy in DMD and suggest preventive interventions.

UI MeSH Term Description Entries
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016189 Dystrophin A muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack dystrophin completely while those with Becker muscular dystrophy have dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.
D016615 Telomere A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs. Telomeres
D048429 Cell Size The quantity of volume or surface area of CELLS. Cell Volume,Cell Sizes,Cell Volumes,Size, Cell,Sizes, Cell,Volume, Cell,Volumes, Cell
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018101 Mice, Inbred mdx A strain of mice arising from a spontaneous MUTATION (mdx) in inbred C57BL mice. This mutation is X chromosome-linked and produces viable homozygous animals that lack the muscle protein DYSTROPHIN, have high serum levels of muscle ENZYMES, and possess histological lesions similar to human MUSCULAR DYSTROPHY. The histological features, linkage, and map position of mdx make these mice a worthy animal model of DUCHENNE MUSCULAR DYSTROPHY. Mice, mdx,Mouse, Inbred mdx,Mouse, mdx,Inbred mdx Mice,Inbred mdx Mouse,mdx Mice,mdx Mouse
D020388 Muscular Dystrophy, Duchenne An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415) Becker Muscular Dystrophy,Duchenne Muscular Dystrophy,Muscular Dystrophy, Becker,Muscular Dystrophy, Pseudohypertrophic,Becker's Muscular Dystrophy,Cardiomyopathy, Dilated, 3B,Cardiomyopathy, Dilated, X-Linked,Childhood Muscular Dystrophy, Pseudohypertrophic,Childhood Pseudohypertrophic Muscular Dystrophy,Duchenne and Becker Muscular Dystrophy,Duchenne-Becker Muscular Dystrophy,Duchenne-Type Progressive Muscular Dystrophy,Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type,Muscular Dystrophy, Becker Type,Muscular Dystrophy, Childhood, Pseudohypertrophic,Muscular Dystrophy, Duchenne Type,Muscular Dystrophy, Duchenne and Becker Types,Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type,Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type,Muscular Dystrophy, Pseudohypertrophic, Childhood,Progressive Muscular Dystrophy, Duchenne Type,Pseudohypertrophic Childhood Muscular Dystrophy,Pseudohypertrophic Muscular Dystrophy, Childhood,Duchenne Becker Muscular Dystrophy,Duchenne Type Progressive Muscular Dystrophy,Muscular Dystrophy, Becker's,Muscular Dystrophy, Duchenne-Becker,Pseudohypertrophic Muscular Dystrophy

Related Publications

Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
October 2011, American journal of cardiovascular drugs : drugs, devices, and other interventions,
Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
November 1995, Rinsho shinkeigaku = Clinical neurology,
Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
January 2004, Archives of disease in childhood,
Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
January 2009, Archives of oral biology,
Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
April 2003, Archives of disease in childhood,
Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
July 1996, Muscle & nerve,
Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
September 2013, Medicinal research reviews,
Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
January 1996, Pediatric neurology,
Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
October 2012, Pediatric cardiology,
Foteini Mourkioti, and Jackie Kustan, and Peggy Kraft, and John W Day, and Ming-Ming Zhao, and Maria Kost-Alimova, and Alexei Protopopov, and Ronald A DePinho, and Daniel Bernstein, and Alan K Meeker, and Helen M Blau
April 2008, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!